QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,066 signal articles · 542 in last 24h · 103,602 total before filter · latest 12m ago
542last 24h
2521last 7d
483● bullish (7d)
259● bearish (7d)
197publishers
AllMacro247Earnings1481M&A141Regulatory16Product4Analyst30
✕ clear all filtersticker: MOHSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Molina Healthcare Q2 Earnings Call Highlights
MarketBeat12d agoneutral
Molina Healthcare Q2 Earnings Call Highlights

Molina Healthcare (NYSE:MOH) reported second-quarter 2026 adjusted earnings per share of $1.51 on $10.2 billion of premium revenue, with management pointing to steady Medicaid performance and stronger-than-expected Medicare duals results while acknowledging continued pressure in its Marketplace busi

Molina Healthcare shares fall after weak revenue outlook overshadows earnings beat (NYSE:MOH)
InvestorsHub13d agoneutral
Molina Healthcare shares fall after weak revenue outlook overshadows earnings beat (NYSE:MOH)

Molina Healthcare (NYSE:MOH) shares dropped more than 9% in premarket trading on Thursday after the health insurer issued a full-year revenue outlook that disappointed investors, despite reporting second-quarter earnings ahead of market expectations. While profitability exceeded forecasts, concerns over slowing revenue growth and ongoing Medicaid headwinds weighed heavily on market sentiment.

Molina (MOH) Q2 Earnings Top Estimates
Zacks13d agoneutral
Molina (MOH) Q2 Earnings Top Estimates

Molina (MOH) delivered earnings and revenue surprises of +10.22% and -0.08%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Molina Healthcare (NYSE:MOH) Posts Q2 CY2026 Sales In Line With Estimates But Stock Drops On Weak Guidance
StockStory13d agobearish
Molina Healthcare (NYSE:MOH) Posts Q2 CY2026 Sales In Line With Estimates But Stock Drops On Weak Guidance

Healthcare insurance company Molina Healthcare (NYSE:MOH) met Wall Street’s revenue expectations in Q2 CY2026, but sales fell by 4.8% year on year to $10.87 billion. On the other hand, the company’s full-year revenue guidance of $42 billion at the midpoint came in 5.1% below analysts’ estimates. Its non-GAAP profit of $1.51 per share was 7.8% above analysts’ consensus estimates.

Why Elevance Earnings Gave Health Insurance Stocks A Cold; UNH Up Next
Investor's Business Daily21d agoneutral
Why Elevance Earnings Gave Health Insurance Stocks A Cold; UNH Up Next

Elevance Health topped Q2 earnings estimates Wednesday, despite falling medical membership, but profit was boosted by one-time "below-the-line" factors and the full-year outlook was underwhelming. ELV stock tumbled, making it among the S&P 500's early laggards. Molina Healthcare, another S&P 500 managed care stock, joined Elevance among the biggest laggards performers in pre-market trading.

Elevance Is Overcoming Medicare Advantage Hurdles. Earnings Could Show It.
Barrons.com21d agobearish
Elevance Is Overcoming Medicare Advantage Hurdles. Earnings Could Show It.

Elevance Health is breaking the Medicare Advantage curse, and the insurer’s earnings could show it on Wednesday. Health insurer stocks have rallied this year after a tough run of rising medical costs that hampered earnings in 2024 and 2025. The results come just a day ahead of the monster of the industry, UnitedHealth Group Wall Street will be watching to see if these two companies can keep the momentum going.

Molina Healthcare (MOH) Is Up 17.4% After Q1 Beat, Guidance Reaffirmation, And MA‑Part D Exit
Simply Wall St.103d agobullish
Molina Healthcare (MOH) Is Up 17.4% After Q1 Beat, Guidance Reaffirmation, And MA‑Part D Exit

Molina Healthcare, Inc. recently reported first‑quarter 2026 results showing revenue of US$10.80 billion, GAAP net income of US$14 million, and GAAP earnings of US$0.27 per diluted share, alongside much higher adjusted earnings and modest declines in revenue and membership. The company also reaffirmed its full‑year 2026 outlook for about US$42.00 billion in premium revenue and at least US$5.00 in adjusted earnings per diluted share, while booking a US$93 million impairment tied to its...